Eli Lilly Beats Dr. Reddy's In Cancer Drug Patent Suit
A drug product for which Dr. Reddy's is seeking U.S. Food and Drug Administration approval would infringe an Eli Lilly and Co. patent covering best-selling cancer treatment Alimta, an Indiana federal...To view the full article, register now.
Already a subscriber? Click here to view full article